Literature DB >> 7496967

T-cell responses to infected autologous monocytes in patients with cutaneous and mucocutaneous leishmaniasis.

A M Cooper1, P C Melby, C L Karp, F Neva, D L Sacks.   

Abstract

Although there is strong evidence that the control and resolution of human leishmanial infections depend primarily on activation of parasite-infected macrophages mediated by lymphokines derived from T cells, less is known about the nature of the responding cell type(s) which is protective or the antigen(s) (Ag[s]) that elicits these cells to respond. Studies using preparations of whole soluble Ag ("dead Ag") show that patients respond to a wide range of leishmanial Ags. The objective of the present study was to characterize the response of T cells from patients with healing or healed cutaneous or mucosal infections to Ag expressed by or derived from actively infected autologous monocytes ("live Ag"). Unfractionated T cells proliferated and produced gamma interferon in response to both live and dead Ags. Depletion of CD4+ T cells resulted in the loss of proliferative and gamma interferon responses to both live and dead Ags. The effect of CD8 depletion, although variable and not limited to the cells stimulated by infected monocytes, was clear for some patients. Expansion of T cells specific for live Ags by using amastigote-infected cells followed by restimulation with fast-protein liquid chromatography-fractionated soluble Ags revealed that a diversity of Ags are associated with infected monocytes. There may, however, be quantitative differences in the expression of certain Ags since prestimulation with live Ag induced higher responses to restimulation in mucocutaneous leishmaniasis patients than in localized cutaneous leishmaniasis patients. Prestimulation with dead Ag induced similar secondary responses in both patient groups.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7496967      PMCID: PMC368253          DOI: 10.1128/cdli.1.3.304-309.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  20 in total

Review 1.  The role of TH1 and TH2 cells in experimental cutaneous leishmaniasis.

Authors:  P Scott
Journal:  Exp Parasitol       Date:  1989-04       Impact factor: 2.011

2.  A role for Lyt-2+ T cells in resistance to cutaneous leishmaniasis in immunized mice.

Authors:  J P Farrell; I Muller; J A Louis
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

3.  Macrophage-parasite interaction in the lesions of cutaneous leishmaniasis. An ultrastructural study.

Authors:  M J Ridley; C W Wells
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

4.  Characterization of in vitro proliferative responses of human lymphocytes to leishmanial antigens.

Authors:  D J Wyler; F I Weinbaum; H R Herrod
Journal:  J Infect Dis       Date:  1979-08       Impact factor: 5.226

Review 5.  Mucosal leishmaniasis ("espundia" Escomel, 1911).

Authors:  P D Marsden
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

6.  Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting.

Authors:  P C Melby; F A Neva; D L Sacks
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

7.  Cell mediated immunity in American cutaneous and mucosal leishmaniasis.

Authors:  E M Carvalho; W D Johnson; E Barreto; P D Marsden; J L Costa; S Reed; H Rocha
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

8.  Parallel regulation of IL-4 and IL-5 in human helminth infections.

Authors:  S Mahanty; J S Abrams; C L King; A P Limaye; T B Nutman
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

9.  Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

Authors:  H W Murray; B Y Rubin; C D Rothermel
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

10.  Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.

Authors:  P Scott; E Pearce; P Natovitz; A Sher
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

View more
  1 in total

1.  Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice.

Authors:  L Carrera; R T Gazzinelli; R Badolato; S Hieny; W Muller; R Kuhn; D L Sacks
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.